Quantum Genomics Societe Anonyme Statistics
Quantum Genomics Societe Anonyme (ALQGC) Stock Statistics & Valuation Metrics
Total Valuation
Quantum Genomics Societe Anonyme has a market cap or net worth of EUR 5.01M. The enterprise value is EUR 7.34T.
- Market Cap
- EUR 5.01M
- Enterprise Value
- EUR 7.34T
Share Statistics
Quantum Genomics Societe Anonyme has 69,709,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 69,709,950
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Quantum Genomics Societe Anonyme’s return on equity (ROE) is 3.62 and return on invested capital (ROIC) is -153.05%.
- Return on Equity (ROE)
- 3.62
- Return on Assets (ROA)
- -25.07
- Return on Invested Capital (ROIC)
- -153.05%
- Return on Capital Employed (ROCE)
- -8.06
- Revenue Per Employee
- 3.333
- Profits Per Employee
- -2.96M
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Quantum Genomics Societe Anonyme is -0.55. Quantum Genomics Societe Anonyme’s PEG ratio is -0.01.
- PE Ratio
- -0.55
- PS Ratio
- 499945.80
- PB Ratio
- -2.05
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Quantum Genomics Societe Anonyme had revenue of 10 and earned -8.89M in profits. Earnings per share was -0.13.
- Revenue
- 10
- Gross Profit
- -1.15M
- Operating Income
- -1.47M
- Pretax Income
- -8.89M
- Net Income
- -8.89M
- EBITDA
- -1.47M
- Earnings Per Share (EPS)
- -0.13
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Quantum Genomics Societe Anonyme pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -176.93%
Stock Price Statistics
- Beta
- -0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Quantum Genomics Societe Anonyme upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Mar 28, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Quantum Genomics Societe Anonyme as a current ratio of 2.05, with Debt / Equity ratio of -107.44%
- Current Ratio
- 2.05
- Quick Ratio
- 2.05
- Debt to Market Cap
- 0.68
- Net Debt to EBITDA
- -1.59
- Interest Coverage Ratio
- -53.51
Taxes
In the past 12 months, Quantum Genomics Societe Anonyme has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Quantum Genomics Societe Anonyme EV to EBITDA ratio is -4.99, with an EV/FCF ratio of 0.00.
- EV to Sales
- 733708.50
- EV to EBITDA
- -4.99
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Quantum Genomics Societe Anonyme has EUR 301.02K in cash and marketable securities with EUR 2.64M in debt, giving a net cash position of -EUR 2.34M billion.
- Cash & Marketable Securities
- EUR 301.02K
- Total Debt
- EUR 2.64M
- Net Cash
- -EUR 2.34M
- Net Cash Per Share
- -EUR 0.03
- Tangible Book Value Per Share
- -EUR 0.04
Margins
Gross margin is -11453070.00%, with operating margin of -14728350.00%, and net profit margin of -88926030.00%.
- Gross Margin
- -11453070.00%
- Operating Margin
- -14728350.00%
- Pretax Margin
- -88926030.00%
- Net Profit Margin
- -88926030.00%
- EBITDA Margin
- -14702370.00%
- EBIT Margin
- -14728340.00%
